ロード中...
Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non–Small-Cell Lung Cancer
PURPOSE: Little is known regarding toxicities and hospitalizations in community-based settings for patients with advanced non–small-cell lung cancer (NSCLC) who received commonly prescribed carboplatin-paclitaxel (CP) or carboplatin-paclitaxel-bevacizumab (CPB) chemotherapy. METHODS: Patients with s...
保存先:
| 出版年: | J Oncol Pract |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Clinical Oncology
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4575400/ https://ncbi.nlm.nih.gov/pubmed/26060223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2014.002980 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|